Text only Text size: A A A Display: Default / High contrast
Medical Research
Health of the Nation: The impact of UK medical schools' research 
Links Links
Publication Date: 29/01/2015 
Size: 4.8mb 
This publication showcases the best medical research from medical schools across the UK. It is comprised of examples of research submitted by medical schools to the Research Excellence Framework 2014, and presents this research in an accessible and powerful manner across four sections: 'Improving clinical practice'; 'Boosting the economy'; 'Delivering benefits to society'; and 'Beyond borders'.

The document can be found through the link on the upper right-hand side of the page.

The accompanying press release, including comment from MSC Chair Professor Iain Cameron, Professor Chris Day, and Academy of Medical Sciences President Professor Sir John Tooke, can be viewed here.

The funding bodies are essential for this research to happen, and those such as the Medical Research Council, Wellcome Trust, and many others are to be commended for their work in supporting UK medical research. The following are links to the original Research Excellence Framework impact statements from which the pieces in Health of the Nation were drawn. If you wish to know more about how this research was funded it is recommended that you refer to the original impact statements below.

  • Single gene diseases
  • Pulse oximetry screening to detect heart disease in newborn babies
  • The Global Registry of Acute Coronary Events (GRACE) risk score for the management of acute coronary syndrome
  • Stopping insulin: A life-changing therapeutic intervention for patients with neonatal diabetes
  • Use of Anti-Tumour Necrosis Factor in the treatment of chronic inflammatory conditions
  • Heart attacks: Improving therapeutic options for patients
  • Saving lives through faecal occult blood (FOB) screening for bowel cancer
  • Reduction of stroke risk by risk stratification and urgent intervention after a transient ischaemic attack or minor stroke
  • Multiple Sclerosis: Developing treatment and improving outcomes measurement
  • Improving outcomes for patients with cystic fibrosis
  • The Moorfields Safer Surgery System: New techniques revolutionise glaucoma surgery
  • Fuller Longer: Helping to develop a new health food range for Marks & Spencer
  • A new mobile application for detecting Alzheimer's disease
  • Chemiluminescent technology underpinning global adoption of test for infectious disease
  • Progression of the Imperial College spin-out 'Circassia' to a multimillion pound specialty biotechnology company
  • Improving lives and transforming services for those with a life-threatening, disabling blood disorder
  • The development of a novel class of anticancer drugs – attracting multimillion dollar investments in clinical trials by nine pharmaceutical companies
  • Economic and health benefits of novel light therapies for the treatment of skin conditions
  • Gene therapy for immunodeficiency diseases
  • Neurosolutions: A commercial partnership between academia industry to develop novel drugs for neurological disorders
  • Reducing gang violence to improve health , in the UK and internationally
  • Worldwide fall in the number of cot deaths
  • Negotiating human bodies and improving donation policies
  • Dolly the sheep – the first cloned mammal
  • The benefits of smoke-free policy in Scotland and worldwide
  • Improving health outcomes and primary care services for osteoarthritis in primary care
  • Mental health consequences of deployment and overstretch in the Armed Forces
  • Introducing patient reported outcome measures (PROMs) into the NHS
  • The Great Sperm Race: Encouraging public understanding of human reproduction
  • Breathing new life into the treatment of respiratory illnesses
  • Biomedical informatics transforming the care of people with diabetes, and with chronic diseases internationally
  • The development of a European Action Plan for strengthening public health capacities and services
  • Global adoption of statins for cardiovascular disease prevention
  • Improving primary care for depression
  • Control of Japanese encephalitis
  • Improving outcomes for children with leukaemia internationally
  • Influencing international health policy to reduce acute waterborne diarrhoeal disease
  • Exposing a treacherous trade
  • Discovery and development of thalidomide analogues for treatment of myeloma and other cancers
  • B cell depletion: an effective therapy in rheumatoid arthritis
Medical Schools Council
Medical Schools Council - Woburn House, 20 Tavistock Square, London, WC1H 9HD
Tel: +44 (0)20 7419 5494 | Fax: +44 (0)20 7380 1482 | Email: admin@medschools.ac.uk
Company No. 8817383, limited by guarantee and registered in England and Wales
Registered Charity No. 1155370